IGG DONOR-SPECIFIC ANTI-HLA ANTIBODY SUBCLASSES AFTER SUCCESSFUL DESENSITIZATION TREATMENT IN KIDNEY TRANSPLANTATION

被引：0
|
作者：
Park, Younhee [1 ]
Kim, Borahm [1 ]
Kim, Hyon-Suk [1 ]
机构：
[1] Yonsei Univ, Severance Hosp, Dept Lab Med, Coll Med, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PO122
引用
收藏
页码：345 / 345
页数：1
相关论文
共 50 条
  • [21] Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Reinsmoen, Nancy L.
    Lai, Chih-Hung
    Vo, Ashley
    Cao, Kai
    Ong, Geraldine
    Naim, Mehrnoush
    Wang, Qi
    Jordan, Stanley C.
    TRANSPLANTATION, 2008, 86 (06) : 820 - 825
  • [22] Development of anti-HLA class II donor specific antibodies after kidney transplantation: determination of IgG subclasses can be useful for the monitoring of antibody severity and graft outcome
    Le Roux, Sandrine
    Vanhove, Bernard
    Devys, Anne
    Cesbron, Anne
    Hourmant, Maryvonne
    Harb, Jean
    TISSUE ANTIGENS, 2010, 75 (05): : 579 - 580
  • [23] Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
    Kaelble, Florian
    Suesal, Caner
    da Silva, Luiza Pego
    Speer, Claudius
    Benning, Louise
    Nusshag, Christian
    Pham, Lien
    Tran, Hien
    Schaier, Matthias
    Sommerer, Claudia
    Beimler, Joerg
    Mehrabi, Arianeb
    Zeier, Martin
    Morath, Christian
    FRONTIERS IN MEDICINE, 2021, 8
  • [24] Mycophenolate mofetil (MMF) effect on anti-HLA donor-specific antibody (DSA) after pediatric living donor transplantation
    Ueno, Takehisa
    Takase, Koki
    Uga, Naoko
    Deguchi, Koichi
    Nomura, Motonari
    Watanabe, Miho
    Kamiyama, Masafumi
    Kimura, Takeshi
    Okuyama, Hiroomi
    TRANSPLANTATION, 2024, 108 (09) : 293 - 293
  • [25] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANTATION
    Dziodzio, T.
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P.
    Bielb, M.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oellinger, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 11 - 11
  • [26] LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION
    Kaelble, Florian
    Susal, Caner
    Da Silva, Luiza Pego
    Speer, Claudius
    Benning, Louise
    Nusshag, Christian
    Schaier, Matthias
    Sommerer, Claudia
    Beimler, Joerg
    Mehrabi, Arianeb
    Zeier, Martin
    Morath, Christian
    TRANSPLANT INTERNATIONAL, 2021, 34 : 182 - 183
  • [27] Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
    Ponsirenas, Renata von Glehn
    Cazarote, Helena B.
    Araujo, Stanley de Almeida
    Wanderley, David Campos
    Shimakura, Silvia
    Valdameri, Joana S.
    Contieri, Fabiana L. C.
    von Glehn, Cristina C. Q. C.
    Susin, Michelle F.
    Sotomaior, Vanessa Santos
    TRANSPLANTATION DIRECT, 2018, 4 (09):
  • [28] DETERMINATION OF ACCEPTABLE DONOR SPECIFIC ANTI-HLA ANTIBODY (DSA) LEVELS PERMISSIVE FOR DECEASED AND LIVING DONOR KIDNEY TRANSPLANTATION (TX) AFTER DESENSITIZATION THERAPY
    Cao, K.
    Lai, C. H.
    Vo, A.
    Ong, G.
    Naim, M.
    Wang, Q.
    Jordan, S.
    Reinsmoen, N. L.
    HUMAN IMMUNOLOGY, 2008, 69 : S9 - S9
  • [29] The Fate of Pre-Transplant Donor-Specific Anti-HLA Antibodies after Transplantation
    Marfo, K.
    Ling, M.
    Greenstein, S.
    Chapochnick-Friedmann, J.
    Glicklich, D.
    Kayler, L.
    de Boccardo, G.
    Kinkhabwala, M.
    Akalin, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 234 - 234
  • [30] Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
    Malheiro, Jorge
    Tafulo, Sandra
    Dias, Leonidio
    Martins, La Salete
    Fonseca, Isabel
    Beirao, Idalina
    Castro-Henriques, Antonio
    Cabrita, Antonio
    TRANSPLANT IMMUNOLOGY, 2015, 32 (02) : 66 - 71
12345